Aardvark says FDA lifted clinical hold on ARD-101 for Prader-Willi hyperphagiaNov 13Quarterly updateAardvark Therapeutics, Inc.ARD-101
Aardvark reports exploratory HERO and OLE data for ARD-101 in Prader-Willi syndromeOct 23Clinical readoutAardvark Therapeutics, Inc.ARD-101
Aardvark posts Phase 2 results for ARD-101 in Prader-Willi SyndromeSep 8Trial updateAardvark Therapeutics, Inc.ARD-101
Aardvark to review unblinded ARD-101 data in Q3 2026 amid FDA clinical holdAug 11Quarterly updateAardvark Therapeutics, Inc.ARD-101